Feedback (LON:FDBK) Stock Crosses Above 50 Day Moving Average – Time to Sell?

Feedback plc (LON:FDBK) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 8.75 and traded as high as GBX 12.50. Feedback shares last traded at GBX 12.50, with a volume of 49,363 shares changing hands.

Feedback Stock Up 5.5%

The firm’s 50 day moving average price is GBX 8.75 and its two-hundred day moving average price is GBX 11.20. The firm has a market capitalization of £5.48 million, a PE ratio of -0.49 and a beta of 0.77.

Insiders Place Their Bets

In related news, insider Emma Oswick (Stuart) acquired 60,459 shares of Feedback stock in a transaction on Tuesday, December 23rd. The shares were purchased at an average cost of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley acquired 60,904 shares of the firm’s stock in a transaction on Tuesday, December 23rd. The shares were bought at an average cost of GBX 8 per share, with a total value of £4,872.32. 7.98% of the stock is currently owned by insiders.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.